How To Use CPT Code 0110U

CPT 0110U describes a specific proprietary laboratory analysis (PLA) test for the detection and quantification of one or more oral oncology drugs and substances in a patient’s body. This article will cover the official description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples of CPT code 0110U.

1. What is CPT Code 0110U?

CPT 0110U is a unique code that represents a proprietary laboratory analysis (PLA) test. It is used to determine the presence or absence and the quantity of one or more oral oncology drugs and substances in a patient’s body. This test utilizes liquid chromatography and tandem mass spectrometry (LC-MS/MS) to precisely identify and quantify the analytes in serum or plasma from a capillary or venous blood sample.

2. Official Description

The official description of CPT code 0110U is a PLA code that applies to the Oral OncolyticAssuranceRX test from Firstox Laboratories, LLC. This test employs liquid chromatography and tandem mass spectrometry (LC-MS/MS) to analyze serum or plasma from a capillary or venous blood specimen. It provides a quantitative report with a steady-state range for the prescribed oral oncology drug(s) when detected.

3. Procedure

1. The test begins by collecting a serum or plasma sample from a capillary or venous blood specimen.
2. The sample is then prepared for analysis using liquid chromatography and tandem mass spectrometry (LC-MS/MS).
3. The LC-MS/MS instrument separates the components of the sample and ionizes them for mass spectrometric analysis.
4. The mass spectrometer provides structural identity and quantification of individual components based on their mass-to-charge ratio.
5. The test determines the presence or absence and the quantity of one or more oral oncology drugs and substances in the patient’s body.
6. A quantitative report is generated, including a steady-state range for the prescribed drug(s) when detected.

4. Qualifying circumstances

CPT code 0110U is used for patients who require evaluation of oral oncology drugs and substances. This test is particularly useful for assessing whether a patient is at a steady-state for prescription oncology drugs, determining the therapeutic or toxic drug levels, evaluating patient compliance with drug treatment, and identifying potential drug-drug interactions. The test is performed on serum or plasma samples obtained from capillary or venous blood specimens.

5. When to use CPT code 0110U

CPT code 0110U should be used when a healthcare provider orders the Oral OncolyticAssuranceRX test from Firstox Laboratories, LLC to evaluate the presence and quantity of oral oncology drugs and substances in a patient’s body. This code should not be reported with any other CPT code, as it represents a specific proprietary laboratory analysis (PLA) test.

6. Documentation requirements

To support a claim for CPT code 0110U, the healthcare provider must document the following information:

• Patient’s information, including name and unique identifier
• Date of service
• Type of specimen collected (serum or plasma)
• Specific oral oncology drug(s) and substances analyzed
• Quantitative results of the analysis
• Steady-state range for the prescribed drug(s) when detected
• Signature of the healthcare provider ordering the test

7. Billing guidelines

When billing for CPT code 0110U, ensure that the test is performed by Firstox Laboratories, LLC for the Oral OncolyticAssuranceRX test. Report one unit of this code for a single specimen analyzed on a single date of service. It is important to note that some payers may separately reimburse for the collection of the specimen, so it is advisable to check with the appropriate payer for their specific guidelines.

8. Historical information

CPT code 0110U was added to the Current Procedural Terminology system on October 1, 2019. There have been no updates or changes to the code since its addition.

9. Examples

1. A patient undergoing oral chemotherapy treatment has their blood sample analyzed using CPT code 0110U to determine the therapeutic drug levels and assess their compliance with the prescribed medication.
2. A physician orders the Oral OncolyticAssuranceRX test for a patient to evaluate the presence and quantity of oral oncology drugs and substances in their body, ensuring that the drug levels are within the therapeutic range.
3. A patient with a history of oral oncology drug therapy undergoes regular monitoring using CPT code 0110U to assess their drug levels and adjust the treatment plan accordingly.
4. A healthcare provider orders the Oral OncolyticAssuranceRX test for a patient to identify any potential drug-drug interactions and optimize their oral oncology drug therapy.
5. A patient receiving oral chemotherapy undergoes CPT code 0110U testing to determine the presence and quantity of the prescribed drug(s) in their body, ensuring that the drug levels are within the therapeutic range.
6. A physician utilizes CPT code 0110U to evaluate the steady-state drug levels of oral oncology drugs in a patient, ensuring that the prescribed treatment is effective and not causing adverse effects.
7. A patient with a history of oral oncology drug therapy undergoes regular monitoring using CPT code 0110U to assess their drug levels and ensure they are within the therapeutic range for optimal treatment outcomes.
8. A healthcare provider orders the Oral OncolyticAssuranceRX test for a patient to evaluate their compliance with oral oncology drug therapy and detect any potential drug-drug interactions.
9. A patient undergoing treatment with oral oncology drugs has their blood sample analyzed using CPT code 0110U to determine the presence and quantity of the prescribed drug(s) and ensure they are within the therapeutic range.
10. A physician orders the Oral OncolyticAssuranceRX test for a patient to assess their steady-state drug levels and optimize the dosage of oral oncology drugs for maximum therapeutic efficacy.